Division of Urology, Department of Surgery, University of Toronto, Toronto, ON, Canada; Division of Urology, Department of Surgery, The Hospital for Sick Children, Toronto, ON, Canada.
Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
J Pediatr Urol. 2024 Apr;20(2):253.e1-253.e6. doi: 10.1016/j.jpurol.2023.11.051. Epub 2023 Dec 1.
The morphology of the bladder and posterior urethra on initial voiding cystourethrogram (VCUG) in posterior urethral valve (PUV) has been proposed as a meaningful early metric for short- and long-term kidney outcomes. Here, we seek to externally validate the proposed association and assess the reliability of PUV morphology characteristics.
We reviewed our institutional database for patients managed for PUV between 2000 and 2022 and included those treated with primary ablation with at least 1 year of follow-up for kidney function. Each VCUG was evaluated by three independent raters for the height-width ratio of the bladder (HW-B), height-width ratio of the posterior urethra (HW-PU), and posterior-anterior urethral ratio (PA-UR), and trabeculation (none, fine, or coarse). We assessed the reliability in these with intra-class coefficient and Fleiss kappa for continuous and categorical data, respectively. We performed univariate analysis with nadir creatinine and five-year follow-up glomerular filtration rate (GFR).
In total, 98 patients met inclusion criteria. The median age at diagnosis and ablation was 10 and 21 days, respectively. Patients with nadir creatinine <0.8 mg/dL had higher follow-up GFR (101 vs. 20 ml/min/1.73 m, p = 0.04), and lower risk of CKD (odds ratio 14.7, p = 0.002). The median value for HW-B was 1.4, median HW-PU was 2.1, and median PA-U was 4.7, There was significant inter-class agreement between all three measures of 0.80, 0.51, and 0.70 (p < 0.001). The inter-rater agreement for bladder trabeculation was fair (Fleiss K = 0.40, p < 0.001). There was no statistically significant correlation between HW-B, HW-PU, PU-A with nadir creatinine (p = 0.07, 0.33, 0.91) or 5-year GFR (0.27, 0.45, 0.62), respectively.
There is significant interest in determining prognostic factors and metrics in PUV. The morphological characteristics on VCUG are reliable and is available information for all boys diagnosed with PUV, resulting in an attractive metric. While we do not demonstrate correlation with kidney outcomes, VCUG features warrant further attention as prognostic factors in PUV.
PUV morphology on initial VCUG is a reliable metric of lower urinary tract deformity but is not associated with 5-year kidney outcomes.
在患有后尿道瓣膜(PUV)的患者中,初始排尿性膀胱尿道造影(VCUG)上膀胱和后尿道的形态已被提出作为短期和长期肾脏结局的有意义的早期指标。在这里,我们试图对外验证这种关联,并评估 PUV 形态特征的可靠性。
我们回顾了我们机构的数据库,以寻找在 2000 年至 2022 年间接受 PUV 治疗的患者,并纳入了至少接受过 1 年随访以评估肾功能的患者。每位患者的 VCUG 均由三位独立的评估者评估,评估指标包括膀胱的高宽比(HW-B)、后尿道的高宽比(HW-PU)和后前尿道比(PA-UR)以及小梁化(无、细或粗)。我们使用组内系数和 Fleiss kappa 分别评估这些指标的可靠性,用于连续和分类数据。我们进行了单变量分析,以评估最小肌酐和 5 年随访肾小球滤过率(GFR)。
共有 98 名患者符合纳入标准。诊断和消融时的中位年龄分别为 10 天和 21 天。肌酐最小值<0.8mg/dL 的患者具有更高的随访 GFR(101 与 20ml/min/1.73m,p=0.04),且慢性肾脏病(CKD)的风险较低(比值比 14.7,p=0.002)。HW-B 的中位数为 1.4,HW-PU 的中位数为 2.1,PA-U 的中位数为 4.7。这三个指标之间存在显著的一致性,分别为 0.80、0.51 和 0.70(p<0.001)。膀胱小梁化的评估者间一致性为中等(Fleiss K=0.40,p<0.001)。HW-B、HW-PU 和 PU-A 与肌酐最小值(p=0.07、0.33 和 0.91)或 5 年 GFR(0.27、0.45 和 0.62)之间无统计学显著相关性。
目前人们对确定 PUV 的预后因素和指标非常感兴趣。VCUG 上的形态特征具有可靠性,是所有诊断为 PUV 的男孩都可获得的信息,因此是一个有吸引力的指标。虽然我们没有证明与肾脏结局相关,但 VCUG 特征作为 PUV 的预后因素值得进一步关注。
初始 VCUG 上的 PUV 形态是下尿路畸形的可靠指标,但与 5 年肾脏结局无关。